Carisma Therapeutics Inc. (CARM) vs Trevena, Inc. (TRVN)
- Carisma Therapeutics Inc. CARM 0.00 −100.00%
- Trevena, Inc. TRVN 0.00 −100.00%
Carisma Therapeutics Inc. and Trevena, Inc. are both Biotechnology companies. Trevena, Inc. is the larger, with a market value of $1.8M against $1.5M — 1.2× the size. Carisma Therapeutics Inc. grew revenue faster over the last twelve months: 170.5% against −83.0%. Carisma Therapeutics Inc. has the higher net margin (14.4% vs −6,233.7%) and the higher return on invested capital (0.00% vs 0.00%). Across the 13 metrics below, Carisma Therapeutics Inc. leads on 8 and Trevena, Inc. on 5.
Valuation
Profitability
| Metric | CARM | TRVN | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | (190.29%) | 65.16% |
| Operating margin | 19.36% | (5,879.85%) | 0.00% |
| Net margin | 14.36% | (6,233.70%) | 0.00% |
| Free cash flow margin | (38.79%) | (4,961.72%) | 0.00% |
| Return on equity | (134.11%) | 344.49% | (56.36%) |
| Return on assets | 33.09% | (105.83%) | (48.04%) |
| Return on invested capital | 0.00% | 0.00% | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack